Post-mortem findings in Spanish patients with COVID-19; a special focus on superinfections
暂无分享,去创建一个
E. Álava | J. Miro | E. de Álava | X. Matías-Guiu | F. Sessa | J. Cisneros | J. Gómez-Román | A. Rivero | J. Miró | M. Sánchez-Conde | J. Miró | I. Ullah | F. Bini | E. Múñez | T. Romero | B. Pérez-Mies | M. Fariñas | I. Aldecoa Ansorregui | J. Fortes Alén | R. Rubio | R. Sánchez | C. Antón | Á. Vidal González | T. Hermida Romero | Carlos Ibero | J. F. Alén | J. Zapirain | Inmaculada Ruiz-Cáceres | G. Merino | D. Corona-Mata | J. Miro | R. Sánchez Sánchez | Ánxela Vidal González | J. Portu Zapirain | C. Salas Anton | M. Riaño | I. Guerra Merino | M. A. Riaño | Raquel Beloqui Pérez de Obanos | Teresa Tabuyo Bello | Diana Corona-Mata | Isabel Guerra Merino | Iban Aldecoa Ansorregui | Raquel Beloqui Pérez de Obanos | Teresa Tabuyo Bello | Necrocovid Study Group | Italy ASST Rhodense | Hermida Romero | Portu Zapirain | Sánchez-Conde Pérez-Mies B | Fortés Alen | Vidal González | Salas Antón | S. Sanchez | Corona-Mata R | Aldecoa Ansorregui | Beloqui Pérez
[1] U. Merle,et al. Lethality of SARS‐CoV‐2 infection—a comparative autopsy study focusing on COVID‐19 development and virus variants , 2023, Histopathology.
[2] I. Bougmiza,et al. Histopathological Findings in COVID-19 Cases: A Systematic Review , 2022, Cureus.
[3] M. Aepfelbacher,et al. Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies? , 2022, Virchows Archiv.
[4] G. Guyatt,et al. Effect of Early Treatment with Ivermectin among Patients with Covid-19 , 2022, The New England journal of medicine.
[5] M. Baniecki,et al. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 , 2022, The New England journal of medicine.
[6] J. Butterton,et al. Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients , 2021, The New England journal of medicine.
[7] R. Menezes,et al. Postmortem findings in COVID-19 fatalities: A systematic review of current evidence , 2021, Legal Medicine.
[8] J. Zamorano,et al. Late Cardiac Pathology in Severe Covid-19. A Postmortem Series of 30 Patients , 2021, Frontiers in Cardiovascular Medicine.
[9] J. Arab,et al. COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence , 2021, Journal of clinical and translational hepatology.
[10] V. Nag,et al. Superinfections in COVID-19 Patients: Role of Antimicrobials , 2021, Dubai Medical Journal.
[11] N. Casamitjana,et al. Early Interventions and Impact of COVID-19 in Spain , 2021, International journal of environmental research and public health.
[12] F. Sessa,et al. Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2) , 2021, Medicina.
[13] P. Boor,et al. Praktische Aspekte von COVID-19-Obduktionen , 2021, Der Pathologe.
[14] F. Heppner,et al. Causes of death and comorbidities in hospitalized patients with COVID-19 , 2021, Scientific Reports.
[15] C. Clancy,et al. Bacterial Superinfections Among Persons With Coronavirus Disease 2019: A Comprehensive Review of Data From Postmortem Studies , 2021, Open forum infectious diseases.
[16] J. Ferreira,et al. Tracking the time course of pathological patterns of lung injury in severe COVID-19 , 2021, Respiratory Research.
[17] L. Pantanowitz,et al. Postmortem Findings Associated With SARS-CoV-2 , 2021, The American journal of surgical pathology.
[18] M. Trauner,et al. COVID-19 autopsies: Procedure, technical aspects and cause of fatal course. Experiences from a single-center , 2020, Pathology - Research and Practice.
[19] E. Turillazzi,et al. Autopsy findings in COVID-19-related deaths: a literature review , 2020, Forensic Science, Medicine and Pathology.
[20] W. Travis,et al. Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID‐19 pneumonia in Wuhan, China , 2020, Histopathology.
[21] Colin G. White-Dzuro,et al. Multisystem effects of COVID-19: a concise review for practitioners , 2020, Postgraduate medicine.
[22] G. Ippolito,et al. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities , 2020, The Journal of infectious diseases.
[23] M. Trauner,et al. Post-mortem viral dynamics and tropism in COVID-19 patients in correlation with organ damage , 2020, Virchows Archiv.
[24] J. Lacy,et al. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series , 2020, The Lancet.
[25] Adenike O Eketunde,et al. A Review of Postmortem Findings in Patients With COVID-19 , 2020, Cureus.
[26] J. van Paassen,et al. A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression , 2020, Modern Pathology.
[27] R. Bruno,et al. Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 , 2020, The New England journal of medicine.
[28] M. Hendaus,et al. Covid-19 induced superimposed bacterial infection , 2020, Journal of biomolecular structure & dynamics.
[29] L. Dodd,et al. Remdesivir for the Treatment of Covid-19 — Final Report , 2020, The New England journal of medicine.
[30] K. Mertz,et al. Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction , 2020, Histopathology.
[31] G. Li Volti,et al. No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science , 2020, Journal of clinical medicine.
[32] Kwok-Hung Chan,et al. Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial , 2020, The Lancet.
[33] Krishna M. Desai,et al. Fatal Superimposed Bacterial Sepsis in a Healthy Coronavirus (COVID-19) Patient , 2020, Cureus.
[34] Amit N. Patel,et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 , 2020, The New England journal of medicine.
[35] R. Piarroux,et al. Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient , 2020, Emerging infectious diseases.
[36] V. S. Santos,et al. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data , 2020, European Journal of Internal Medicine.
[37] Y. Ho,et al. SARS-CoV-2: A Storm is Raging. , 2020, The Journal of clinical investigation.
[38] Ke Ma,et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study , 2020, BMJ.
[39] D. Raoult,et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial , 2020, International Journal of Antimicrobial Agents.
[40] W. Tu,et al. Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[41] MingKun Li,et al. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[43] T. Velavan,et al. The COVID‐19 epidemic , 2020, Tropical medicine & international health : TM & IH.
[44] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[45] R. Hunter,et al. The Importance of the Autopsy in Medicine: Perspectives of Pathology Colleagues , 2019, Academic pathology.
[46] A. Katzenstein,et al. Diffuse alveolar damage--the role of oxygen, shock, and related factors. A review. , 1976, The American journal of pathology.